-
Just how many data points are collected for every patient every day in your hospital? It numbers in the thousands, and much of the information is never used. Imagine what you could do if you harnessed all the data you have at your fingertips.
-
From losing money to bonuses in one year.
-
Two years ago, the federal government put in place a mechanism for determining quality goals and strategies for the healthcare system.
-
So much to do, so little time.
-
Have you heard of a CXO?
-
-
When the cure causes harm
-
The Food and Drug Administrations Center for Drug Evaluation and Research (FDA CDER) has issued a draft guidance to make it easier for development and testing of Alzheimers treatments in patients at an early stage of the disease.
-
In days not so long ago, when all IRB members received heavy stacks of paper packets containing protocol submissions before each meeting, research institutions and regulatory compliance officials never questioned whether they would read the work before meetings. It was assumed they would be well-prepared for discussions.
-
Drugmaker GlaxoSmithKline (GSK) has announced its intentions to start publishing clinical study reports (CSRs) and clinical trial results in an effort for increased transparency, making it the first major drug company to do so.
